<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3339">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02125201</url>
  </required_header>
  <id_info>
    <org_study_id>EMC-0089-13 - CTIL</org_study_id>
    <nct_id>NCT02125201</nct_id>
  </id_info>
  <brief_title>Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention</brief_title>
  <official_title>Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neonatal intensive care unit   patients undergoes many painful procedures during their
      hospitalization. Effective pain control in such procedures as intubation,  catheterization,
      central line insertion, chest tube insertion, etc. is an important part of treatment.
      Opioids administration is a common practice for acute pain prevention.  Fentanyl is the
      preferred  opioid due to it rapid onset and short duration of action.

      Fentanyl may be  given intravenously, transcutaneous transmucosal  and intranasal.
      Intranasal administration is practiced for about 20 years. A rich vascular supply in a nose
      provides rapid absorption of the drug. This uninvasive root is now popular for pain
      prevention and treatment. There are about 20 trials with intranasal fentanyl  administration
      to children from  6 month old to 18 years. The investigators did not find information about
      this way of administration in neonates.

      In our pilot study the investigators want  to check if intranasal administration of fentanyl
      is safe and effective in pain prevention in term and preterm neonates during invasive
      procedures and to compare it with intravenous route of administration.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain scale - N-PASS</measure>
    <time_frame>before the intervention  and till one our after intervention</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>intranasal fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intranasal Fentanyl 1.5-2 mcg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous Fentanyl 1-1.5 mcg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>A neonate will recieve Fentanyl intranasal or intravenous 5 minutes before the procedure The nurse will  check his pain scale If the pain scale will be more than 4 the neonate will recieve the second dose of Fentanyl</description>
    <arm_group_label>intranasal fentanyl</arm_group_label>
    <arm_group_label>intravenous fentanyl</arm_group_label>
    <other_name>Beatryl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Term and preterm neonates  that require invasive procedures (elective or semielective
        intubation, central line insertion , chest drain or abdominal drain)

        Exclusion Criteria:

          1. Neonates with prolonged analgesic treatment before the procedure

          2. Neonates with neurologic problem which can interact with pain assessment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marina Peniakov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEmek Medical Center, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NICU</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marina Peniakov</last_name>
      <phone>972545347449</phone>
      <email>marina_pe@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Marina Peniakov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 28, 2014</lastchanged_date>
  <firstreceived_date>March 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Peniakov Marina</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>intranasal fentanyl</keyword>
  <keyword>newborn</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
